Press Release
Category Added in a WPeMatico Campaign
-
AvenCell Therapeutics Announces IND Clearance and EMA Approval of Clinical Trial Application (CTA) for the QUADvance Study, a Phase I/II trial evaluating AVC-203, a Novel Allogeneic CD19/CD20 CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-cell malignancies
CAMBRIDGE, Mass., Dec. 4, 2025 /PRNewswire/ — AvenCell Therapeutics, Inc., a leading clinical-stage cell therapy company focused on advancing both switchable…
Read More » -
EUROPE’S 50 BEST BARS TO DEBUT, SPOTLIGHTING BARS ACROSS THE CONTINENT
50 Best, the organisation behind The World’s 50 Best Bars, launches brand-new list and awards programme in Europe for the…
Read More » -
InsightRX Surpasses 1,000 Hospital Deployments as the Most Widely Used AI Precision Dosing Software
SAN FRANCISCO, Dec. 4, 2025 /PRNewswire/ — InsightRX today announced the company’s AI precision dosing software is now deployed across…
Read More » -
New Survey Reveals Food Processors Face Escalating Energy Challenges Amid Grid Constraints and Rising Costs
BOSTON, Dec. 4, 2025 /PRNewswire/ — A new survey jointly authored by AlphaStruxure, Schneider Electric, and Endeavor Business Intelligence reveals…
Read More »
